Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06626048 · ClinicalTrials.gov registry record · NA
Optimizing an Integrated Mind and Body Treatment for Insomnia: The SLEEPS Study
A NA study of Insomnia Disorder, sponsored by University of California, San Francisco.
- Active
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT06626048: Active NA study of Insomnia Disorder, sponsored by University of California, San Francisco.
NCT06626048 is a NA study of Insomnia Disorder that is active but no longer recruiting, run by University of California, San Francisco. The registered enrollment target is 10 participants, below the 474-participant average among 8 other Insomnia Disorder trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06626048, a NA study of Insomnia Disorder, is active but no longer recruiting, sponsored by University of California, San Francisco.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
This single-arm feasibility trial will provide digital cognitive behavioral therapy for insomnia (CBT-I) and passive body heating (PBH) sessions using a sauna blanket over a 9-week treatment period to adults aged 18 years or older with insomnia disorder.
Primary Outcome
Proportion of eligible prospective participants who consent to complete at least 6 weeks of at least 3 PBH sessions per week over the 9-week intervention period.
Conditions Studied
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy for Insomnia
- DEVICE Passive Body Heating (PBH)
Study Locations (1)
California
- University of California San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-02-07 |
| Est. Completion | 2026-01-28 |
| Phase | NA |
What the registry record for NCT06626048 still lists
NCT06626048 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 474-participant average among 8 other Insomnia Disorder trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Insomnia Disorder appearing as the primary indexed condition, and to 2 interventions - of which Cognitive Behavioral Therapy for Insomnia is the first listed.
NCT06626048 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06626048 about?
NCT06626048 is a clinical study titled "Optimizing an Integrated Mind and Body Treatment for Insomnia: The SLEEPS Study". This single-arm feasibility trial will provide digital cognitive behavioral therapy for insomnia (CBT-I) and passive body heating (PBH) sessions using a sauna blanket over a 9-week treatment period to adults aged 18 years or older with insomnia disorder.
What is the current status of trial NCT06626048?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2025-02-07. Estimated completion is 2026-01-28.
What conditions does trial NCT06626048 study?
This clinical trial studies the following conditions: Insomnia Disorder.
What interventions are being tested in trial NCT06626048?
The interventions under investigation include: Cognitive Behavioral Therapy for Insomnia (BEHAVIORAL), Passive Body Heating (PBH) (DEVICE).
Who is sponsoring clinical trial NCT06626048?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06626048 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insomnia Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06626048's enrollment target sits among peer trials
10 8th of 8 higher than 1 of 8 other Insomnia Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Insomnia Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Brief Behavioral Treatment for Insomnia in Veterans With Posttraumatic Stress Disorder
RECRUITING · NA
-
Assessing Modified CBTi in Adults with Insomnia Disorder
RECRUITING · NA
-
Optimizing an Integrated Mind and Body Treatment for Insomnia: The SLEEPS Study 2
RECRUITING · NA
-
Sleep Well 24 (SWELL24) Healthy Sleep-Wake Behaviors in Older Adults
COMPLETED · NA
-
Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia
RECRUITING · Phase 3
-
Database Study to Provide Information on Pregnancy and Infant Outcomes Among Women Exposed to QUVIVIQ (Daridorexant)
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI